Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125814132 | 12581413 | 2 | F | 20160719 | 20160914 | 20160721 | 20160919 | PER | PHEH2016US017984 | NOVARTIS | 86.61 | YR | F | Y | 66.21000 | KG | 20160920 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125814132 | 12581413 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | N | 21588 | 400 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125814132 | 12581413 | 1 | Gastrointestinal stromal tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125814132 | 12581413 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125814132 | 12581413 | Abdominal pain upper | |
| 125814132 | 12581413 | Cardiac disorder | |
| 125814132 | 12581413 | Eye disorder | |
| 125814132 | 12581413 | Haemorrhage | |
| 125814132 | 12581413 | Peripheral swelling | |
| 125814132 | 12581413 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125814132 | 12581413 | 1 | 20160616 | 20160719 | 0 |